Burzynski: Poland antineoplaston publications

1990 – Theoretical investigations on the structure and potential binding sites of antineoplaston A10 and experimental findings
http://www.ncbi.nlm.nih.gov/m/pubmed/2092960
Institute of Inorganic Chemistry, Technical University of Wroclaw, Poland
Drugs Exp Clin Res 16 (7): 343-9 (1990)
Drugs Exp Clin Research

6/20/1991 – MNDO Studies on the structure of Antineoplaston A10, glutarimide and piperidine
MNDO studies on the structure of antineoplaston A10, glutarimide and piperidine
Journal of Molecular Structure: THEOCHEM, Elsevier
Volume 231, 20 June 1991, Pages 357–366
http://dx.doi.org/10.1016/0166-1280(91)85232-V
Institute of Inorganic Chemistry and Metallurgy of Rare Elements, Technical University of Wrocław, Wrocław, Poland
http://www.sciencedirect.com/science/article/pii/016612809185232V

1992 – [Antineoplastons–structure, chemical properties and mechanism of activity]
http://www.ncbi.nlm.nih.gov/m/pubmed/1308583
Katedra i Zakład Anatomii Patologicznej Akademii Medycznej, Wrocławiu
Postepy Hig Med Dosw (Online) 46(6):659-68 (1992)

1/1/1994 – The influence of antineoplaston A5 on the central dopaminergic structures
http://www.ncbi.nlm.nih.gov/m/pubmed/7813388
Department of Pharmacology, Medical Academy, Lublin, Poland
Drugs Exp Clin Res. 1994;20(4):161-7

1995 – The influence of antineoplaston A5 on particular subtypes of central dopaminergic receptors
http://www.ncbi.nlm.nih.gov/m/pubmed/8529528
Department of Pharmacology, Medical Academy, Lublin, Poland
Drugs Exp Clin Res. 1995;21(4):153-6

1996 – A POTENTIOMETRIC STUDY OF METAL ION COMPLEXES OF ANTINEOPLASTON A10, A NEW ANTITUMOUR AGENT
J Coord Chem 38 (1):101-106 (1996)
DOI: 10.1080/00958979608022694
Journal of Coordination Chemistry
http://assets0.pubget.com/paper/pgtmp_074a46e8fbc10fdf29d5ced2c688e838/A_POTENTIOMETRIC_STUDY_OF_METAL_ION_COMPLEXES_OF_ANTINEOPLASTON_A10__A_NEW_ANTITUMOUR_AGENT

http://pubget.com/paper/pgtmp_074a46e8fbc10fdf29d5ced2c688e838/A_POTENTIOMETRIC_STUDY_OF_METAL_ION_COMPLEXES_OF_ANTINEOPLASTON_A10__A_NEW_ANTITUMOUR_AGENT

http://www.tandfonline.com/doi/abs/10.1080/00958979608022694

http://hero.epa.gov/index.cfm?action=reference.details&reference_id=1191108

http://www.cancer.duke.edu/btc/docs/patient_education/cam.pdf

http://cancer.ucsd.edu/treatments/cam/therapies/Documents/CAM_Cancer_Patient_Guide.pdf

http://nccam.nih.gov/health/cancer/camcancer.htm

http://www.longwoodherbal.org/antineoplastons/antineoplastons.PDF

11-12/1997 – [Assessment of early treatment results with antineoplaston AS2-1 in subacute sclerosing panencephalitis]
http://www.ncbi.nlm.nih.gov/m/pubmed/9591301
Neurol Neurochir Pol. 1997 Nov-Dec; 31 (6):1147-56. Article in Polish
I Kliniki Neurologicznej IPiN w Warszawie
Neurol Neurochir Pol 31 (6):1147-56 (1997)

1999 – [The evaluation of the use of antineoplaston AS2-1 treatment in subacute sclerosing panencephalitis]
http://www.ncbi.nlm.nih.gov/m/pubmed/10612094
I Kliniki Neurologicznej Instytutu Psychiatrii i Neurologii w Warszawie.
33 (4):797-805
Neurol Neurochir Pol 33(4):797-805 (1999)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s